Naomi Kresge
An employee looks at data on screens in the high-tech command center at the Novartis AG campus in Basel, Switzerland.
BUSINESS / Companies
Jan 10, 2024
Swiss pharma firms plot different paths to blockbuster drugs
Roche has doubled down on Alzheimer’s and boosted research and development spending across its portfolio.
A pharmacist holds a box of Novo Nordisk A/S Wegovy brand semaglutide medication.
BUSINESS / Companies
Dec 7, 2023
Can Wegovy fight alcoholism? For Big Pharma, this isn’t a priority
Reluctance underscores reasons why no new treatment has been approved for alcoholism in nearly 20 years.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
Oct 13, 2022
Omicron’s staying power could pave the way for a predictable COVID-19 pattern
Any successor to omicron will face an uphill battle, as it will need to be both more transmissible and better able to sidestep the immunity people have built.
Japan Times
WORLD / Science & Health
May 16, 2022
How omicron infection turbocharges vaccinated people’s immunity
The data comes as omicron continues to fuel outbreaks around the world, most notably in China, where residents of Shanghai have endured almost six weeks of lockdown.
Japan Times
Dec 2, 2021
Vaccines likely to protect against severe cases of omicron, WHO scientist says
The WHO's statement is the latest in a series of efforts from health authorities to reassure the public on vaccines even as many questions about the new variant remain unanswered.
Japan Times
Sep 14, 2021
Most people don’t need COVID-19 vaccine booster, scientists say
Governments would be better served to focus on immunizing the unvaccinated and to wait for more data on which boosters would be most effective and at what doses, the experts said.
Japan Times
WORLD / Politics / FOCUS
Mar 25, 2021
Merkel’s COVID-19 crisis is changing the shape of upcoming election
Reverberations from a quickly reversed Easter lockdown decision could have significant consequences for the future of Europe's largest economy.
Japan Times
Feb 22, 2021
Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows
The study provides the first real-world indication that the immunization will curb transmission of the coronavirus, but experts cautioned that more data is needed.
Japan Times
WORLD / Society
Sep 24, 2013
'Grandma export' exposes Germany's struggle with care
Sonja Miskulin has forgotten her beloved cat, Pooki. She can't remember whether she has grandchildren and has no memory of her nine-hour journey one recent Sunday to forever leave behind her home in Germany.


The Japanese government updated its English education guidelines in 2017 to emphasize communication over grammar and memorization. Public school teachers are incredibly busy, however, which means schools haven’t been able to implement changes uniformly. Private and alternative schools are attempting to remedy this.
The language of opportunity: Bilingual education is on the rise in Japan